ENVERIC BIOSCIENCES, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ENVERIC BIOSCIENCES, INC. (ENVB) reported Adjustments to Additional Paid in Capital, Warrant Issued of $267.68 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-27
- ENVERIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $267.68K.
- ENVERIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $32.15K.
- ENVERIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2016-12-31 was $0.00.
- ENVERIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2016-09-30 was $0.00.
- ENVERIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $267.68K, a 84.13% decline from fiscal 2023.
- ENVERIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $1.69M.
- ENVERIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $32.15K, a 29.24% increase from fiscal 2019.
- ENVERIC BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $24.88K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2024-12-31 | $267.68K 10-K · filed 2026-03-27 | |||
| 2024-03-31 | $267.68K 10-Q · filed 2025-11-14 | |||
| 2023-12-31 | $1.69M 10-K · filed 2025-03-28 | |||
| 2020-12-31 | $32.15K 10-K · filed 2022-03-31 | |||
| 2020-03-31 | $32.15K 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $24.88K 10-K · filed 2021-04-01 | |||
| 2016-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-04-04 | $0.00 derived: sum of 2 quarters · filed 2017-04-04 | -$5.00M 10-K/A · filed 2017-04-04 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$5.00M 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | -$5.00M 10-Q · filed 2016-08-12 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$34.52K derived: sum of 2 quarters · filed 2016-11-14 | -$159.52K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$34.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$159.52K 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | -$125.00K 10-Q · filed 2016-05-16 | -$125.00K 10-KT · filed 2016-03-15 | ||
| 2014-03-31 | -$10.00K 10-KT · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |